As of 2023, mortality due to genitourinary system diseases in Canada stood at an undisclosed level expressed in thousands of female deaths. From 2024 onwards, forecasted data indicates a steady year-on-year increase, with percentage growth as follows: 2024 to 2025 records a rise of approximately 1.22%, 2025 to 2026 at roughly 1.2%, and similar growth patterns continue up to 2028. The cumulative average growth rate (CAGR) over the five-year period is anticipated to maintain a consistent upward trajectory, reflecting an ongoing trend of gradual increases in mortality.
Future trends to watch for include advancements in medical technology and treatment options which could potentially mitigate this rise. The impact of public health initiatives focusing on prevention and early intervention for genitourinary diseases may also influence these numbers. Monitoring demographic shifts and lifestyle changes will be crucial for understanding and potentially curbing this mortality trend in Canada.
